- Home
- ZTEK vs MYO Comparison
ZTEK vs MYO Comparison
Compare ZTEK & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTEK
- MYO
- Stock Information
- Founded
- ZTEK 2008
- MYO 2004
- Country
- ZTEK Canada
- MYO United States
- Employees
- ZTEK N/A
- MYO N/A
- Industry
- ZTEK Major Chemicals
- MYO Industrial Specialties
- Sector
- ZTEK Industrials
- MYO Health Care
- Exchange
- ZTEK Nasdaq
- MYO Nasdaq
- Market Cap
- ZTEK 165.9M
- MYO 153.0M
- IPO Year
- ZTEK N/A
- MYO 2017
- Fundamental
- Price
- ZTEK $1.16
- MYO $2.13
- Analyst Decision
- ZTEK
- MYO Strong Buy
- Analyst Count
- ZTEK 0
- MYO 4
- Target Price
- ZTEK N/A
- MYO $9.13
- AVG Volume (30 Days)
- ZTEK 33.2K
- MYO 815.7K
- Earning Date
- ZTEK 08-13-2025
- MYO 08-05-2025
- Dividend Yield
- ZTEK N/A
- MYO N/A
- EPS Growth
- ZTEK N/A
- MYO N/A
- EPS
- ZTEK N/A
- MYO N/A
- Revenue
- ZTEK $607,016.00
- MYO $38,628,624.00
- Revenue This Year
- ZTEK N/A
- MYO $55.29
- Revenue Next Year
- ZTEK N/A
- MYO $27.18
- P/E Ratio
- ZTEK N/A
- MYO N/A
- Revenue Growth
- ZTEK 2826.26
- MYO 97.60
- 52 Week Low
- ZTEK $0.50
- MYO $2.02
- 52 Week High
- ZTEK $1.84
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- ZTEK 30.38
- MYO 19.25
- Support Level
- ZTEK $1.03
- MYO $2.02
- Resistance Level
- ZTEK $1.16
- MYO $2.89
- Average True Range (ATR)
- ZTEK 0.10
- MYO 0.16
- MACD
- ZTEK -0.03
- MYO -0.01
- Stochastic Oscillator
- ZTEK 17.02
- MYO 1.15
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).